Stephen Shield, M.D.
NPI 1073590071 · Allergy & Immunology Physician · Williamsburg, VA
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1073590071
- Entity type
- Individual
- Primary specialty
- Allergy & Immunology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 0101049643 (VA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
7,674 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test for Allergy Using Allergenic Extract95004 | 3,384 | $3 |
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 1,460 | $14 |
| Professional Service for Multiple Injections of Allergen95117 | 891 | $12 |
| Test for Allergy Using Allergenic Extract Injected Into Skin95024 | 478 | $8 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 368 | $14 |
| Professional Service for Single Injection of Allergen95115 | 329 | $10 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 26 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Azelastine Hcl | 129 | 49 |
| Montelukast Sodium | 67 | 23 |
| Ipratropium Bromide | 47 | 22 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 39 | 27 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 38 | 12 |
| Beclomethasone Dipropionatebrand: Qvar Redihaler | 35 | 11 |
| Fluticasone Furoate |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$17,410 across 129 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-12-30
- Last updated
- 2023-11-01
- Certified
- 2023-11-01
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.